CHIRICOZZI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 6.650
EU - Europa 625
AS - Asia 394
SA - Sud America 42
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 7.722
Nazione #
US - Stati Uniti d'America 6.643
SG - Singapore 172
CN - Cina 116
IT - Italia 111
UA - Ucraina 83
DE - Germania 75
SE - Svezia 56
FR - Francia 55
RU - Federazione Russa 55
IE - Irlanda 54
HK - Hong Kong 44
BR - Brasile 37
PL - Polonia 37
GB - Regno Unito 34
FI - Finlandia 22
IN - India 17
KR - Corea 17
NL - Olanda 17
CA - Canada 5
CH - Svizzera 5
KG - Kirghizistan 5
RO - Romania 5
UZ - Uzbekistan 5
AT - Austria 4
AR - Argentina 3
BE - Belgio 3
EU - Europa 3
MY - Malesia 3
TR - Turchia 3
AU - Australia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
HR - Croazia 2
ID - Indonesia 2
MA - Marocco 2
OM - Oman 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
LT - Lituania 1
MX - Messico 1
PA - Panama 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 7.722
Città #
Woodbridge 2.027
Wilmington 1.735
Houston 1.510
Fairfield 218
Chandler 145
Singapore 137
Ann Arbor 126
Ashburn 113
Seattle 82
Cambridge 76
Jacksonville 68
Dearborn 64
Dublin 54
Hong Kong 44
Medford 44
Kraków 37
Zhengzhou 36
Rome 35
New York 34
Santa Clara 27
Lawrence 21
The Dalles 18
San Diego 15
Beijing 14
Council Bluffs 14
Menlo Park 12
Milan 10
Norwalk 10
Shanghai 9
Amsterdam 8
Palo Alto 8
Hefei 7
Detroit 6
Moscow 6
Nanjing 6
Boardman 5
Kunming 5
São Paulo 5
Engelhard 4
Fuzhou 4
Helsinki 4
London 4
Munich 4
Nanchang 4
Redwood City 4
Brussels 3
Esslingen am Neckar 3
Guangzhou 3
Pune 3
Salt Lake City 3
Trieste 3
Verona 3
Vienna 3
Auburn Hills 2
Bari 2
Basel 2
Brno 2
Catania 2
Changsha 2
Coralville 2
Ferrara 2
Hebei 2
Hounslow 2
Indianapolis 2
Indore 2
Jakarta 2
Jinan 2
Kitchener 2
Lucknow 2
Ludhiana 2
Monte Porzio Catone 2
Motherwell 2
Mountain View 2
Mumbai 2
Mülheim 2
Naples 2
New Delhi 2
Ningbo 2
Nottingham 2
Pisa 2
Ribeirão Preto 2
Sacrofano 2
Tianjin 2
Torino 2
Turin 2
Wuhan 2
Xian 2
Zagreb 2
Araguari 1
Augusta 1
Aznalcázar 1
Baghdad 1
Barbacena 1
Berlin 1
Berrien Springs 1
Blida 1
Bologna 1
Bombinhas 1
Buffalo 1
Cairo 1
Totale 6.925
Nome #
Efficacy and safety of infliximab in psoriatic patients over the age of 65 504
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 485
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 440
Apremilast for the treatment of psoriasis. 427
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 422
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 413
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 402
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 395
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 373
Quality-of-life impairment in hidradenitis suppurativa 362
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 358
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 357
Immunologic biomarkers for clinical and therapeutic management of psoriasis 342
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 336
Tofacitinib for the treatment of moderate-to-severe psoriasis 328
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 327
Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study 298
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 297
Assessement of disease severity and treatment effectiveness in hidradenitis suppurtiva 296
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 284
Alexithymia affects patients with hidradenitis suppurativa 272
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 58
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 40
Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa 27
Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab 23
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 17
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 15
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 14
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 9
Totale 7.921
Categoria #
all - tutte 16.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020381 0 0 0 0 0 0 0 0 0 157 109 115
2020/20211.048 112 113 132 128 92 89 145 115 45 24 43 10
2021/2022211 13 22 21 13 8 19 10 8 14 20 17 46
2022/2023323 27 29 15 49 29 66 24 18 36 3 13 14
2023/2024177 19 1 10 5 13 39 8 16 4 15 7 40
2024/2025492 23 133 65 66 14 41 73 30 35 12 0 0
Totale 7.921